Clinical trial
Methylphenidate and Parkinson's Disease
NCT00359723 · Oregon Health and Science University, Other · Completed
Key facts
| NCT number | NCT00359723 |
|---|---|
| Title | Methylphenidate and Parkinson's Disease |
| Official title | Subacute Trial of Methylphenidate in Parkinson's Disease |
| Lead sponsor | Oregon Health and Science University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | methylphenidate |
| Enrollment | 13 |
| Start date | Jul 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Aug 2, 2006 |
| Last update posted | Nov 29, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: